A Randomized Phase 1 Study of Safety, Tolerability, and Pharmacokinetics of MK-1088, a Novel Dual Adenosine Receptor Antagonist, in Healthy Adult Participants
Investigational New Drugs(2024)
关键词
MK-1088,A2A receptors,A2B receptors,Dual inhibition,Safety,Pharmacokinetics
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要